ORIFARM PI A/S: Financial statements 2017
CVR: 27347177
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ORIFARM PI A/S (CVR 27347177) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -174,000 and a net result of DKK 99,654,000 compared with DKK 50,075,000 the year before. Equity in the 2017 report amounted to DKK 357,512,000. The solvency ratio was 80.4%.
- Gross Profit
- DKK -174,000
- Profit/Loss
- DKK 99,654,000
- Equity
- DKK 357,512,000
- Total Assets
- DKK 444,784,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -174K | 99.7M | 357.5M | - |
| 2016 | - | -203K | 50.1M | 256.8M | - |
| 2015 | - | -27K | 25.3M | 206.2M | - |
| 2014 | - | -30K | 18.7M | 59M | - |
| 2013 | - | -30K | 18.5M | 42.6M | - |
Official annual report
Keep an eye on ORIFARM PI A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ORIFARM PI A/S has published its annual report for 2016. Gross profit came to DKK -203,000, and the net result was DKK 50,075,000.
About ORIFARM PI A/S
ORIFARM PI A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Finansielle holdingselskaber. The company was previously named ORIFARM HOLDING A/S. The management consists of Thomas Brandhof. The board consists of Hans Carl Bøgh-Sørensen (chair), Mads Fink Eriksen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -446,000 and a net result of DKK 298,665,000 compared with DKK 320,939,000 the year before. Equity in the 2025 report amounted to DKK 1,391,995,000.